Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:00 pm Sale |
2024-12-31 | 13G | Akebia Therapeutics, Inc. AKBA |
Satter Muneer A | 5,747,906 2.600% |
-10,457,213 (-64.53%) |
Filing History |
| 2025-02-14 4:59 pm Sale |
2024-12-31 | 13G | Aadi Bioscience, Inc. AADI |
Satter Muneer A | 659 0.000% |
-1,630,171 (-99.96%) |
Filing History |
| 2024-04-16 5:16 pm Sale |
2024-04-02 | 13D | Rein Therapeutics Inc. RNTX |
Satter Muneer A | 830,466 4.900% |
-186,567 (-18.34%) |
Filing History |
| 2024-03-05 4:30 pm Purchase |
2024-03-05 | 13D | Rein Therapeutics Inc. RNTX |
Satter Muneer A | 1,017,033 5.900% |
9,545 (+0.95%) |
Filing History |
| 2024-02-09 4:00 pm Purchase |
2023-12-31 | 13G | Akebia Therapeutics, Inc. AKBA |
Satter Muneer A | 16,205,119 8.600% |
1,115,000 (+7.39%) |
Filing History |
| 2023-11-03 4:30 pm Purchase |
2023-10-31 | 13D | Rein Therapeutics Inc. RNTX |
Satter Muneer A | 1,007,488 19.900% |
1,007,488 (New Position) |
Filing History |
| 2023-02-17 4:00 pm Purchase |
2023-02-10 | 13D | Annexon, Inc. ANNX |
Satter Muneer A | 7,679,521 15.000% |
2,647,058 (+52.60%) |
Filing History |
| 2023-02-10 1:08 pm Purchase |
2022-12-31 | 13G | Akebia Therapeutics, Inc. AKBA |
Satter Muneer A | 15,090,119 8.200% |
1,225,789 (+8.84%) |
Filing History |
| 2023-02-10 1:04 pm Purchase |
2022-12-31 | 13G | Aadi Bioscience, Inc. AADI |
Satter Muneer A | 1,630,830 6.700% |
336,045 (+25.95%) |
Filing History |
| 2022-12-19 4:10 pm Purchase |
2022-12-08 | 13G | Akebia Therapeutics, Inc. AKBA |
Satter Muneer A | 13,864,330 7.500% |
10,797,287 (+352.04%) |
Filing History |
| 2022-10-04 4:01 pm Purchase |
2022-09-26 | 13G | Aadi Bioscience, Inc. AADI |
Satter Muneer A | 1,294,785 5.300% |
1,294,785 (New Position) |
Filing History |
| 2022-07-18 4:45 pm Purchase |
2022-07-07 | 13D | Annexon, Inc. ANNX |
Satter Muneer A | 5,032,463 10.400% |
3,077,485 (+157.42%) |
Filing History |
| 2022-02-10 4:06 pm Unchanged |
2021-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Satter Muneer A | 185,625 4.700% |
0 (Unchanged) |
Filing History |
| 2021-11-12 4:03 pm Sale |
2021-11-10 | 13D | Aadi Bioscience, Inc. AADI |
Satter Muneer A | 374,785 1.790% |
-4 (-0.00%) |
Filing |
| 2021-02-12 07:03 am Unchanged |
2020-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Satter Muneer A | 185,625 6.700% |
0 (Unchanged) |
Filing History |
| 2021-02-12 07:01 am Sale |
2020-12-31 | 13G | Albireo Pharma, Inc. ALBO |
Satter Muneer A | 0 0.000% |
-832,000 (Position Closed) |
Filing History |
| 2021-02-12 07:00 am Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Satter Muneer A | 1,954,978 5.100% |
1,954,978 (New Position) |
Filing History |
| 2021-01-08 4:04 pm Purchase |
2021-01-06 | 13D | Aileron Therapeutics, Inc. ALRN |
Satter Muneer A | 1,017,040 19.900% |
450,000 (+79.36%) |
Filing History |
| 2021-01-04 4:01 pm Purchase |
2020-12-22 | 13G | Assembly Biosciences, Inc. ASMB |
Satter Muneer A | 185,625 6.700% |
185,625 (New Position) |
Filing History |
| 2020-11-20 5:31 pm Unchanged |
2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
Satter Muneer A | 374,789 11.900% |
0 (Unchanged) |
Filing History |